Shipments. Total shipments in the third quarter of 2024 were $261 million, up 23% from the third quarter of 2023. Total shipments include deliveries for revenue in the quarter and deliveries of first ...
These devices could serve as valuable tools for biomedical research and may have potential for clinical applications in the future. Novel magnetic nanodiscs could provide a much less invasive way of ...
Pricing strategy, therefore, plays a critical role in balancing innovation with market readiness, especially as biopharmaceutical R&D costs can reach upwards of $2.6 billion per drug ... making him ...